Low prevalence of HIV in the northern Cameroon: contribution of some AIDS restriction genes and potential implications for gene therapy

The higher frequency of HIV-protective alleles in the northern regions may be a contributing factor to the lower prevalence of HIV. Nevertheless, this should be reinforced by other preventive and surveillance methods to guarantee the sustained low prevalence. HIV can develop resistance through the process of mutation, but the host targets themselves are genetically stable. The study of these host genetic restriction factors is of great value in the design of a practical cure for HIV infection or an effective vaccine.

Authors

Institutions

Publication Details

Journal
Frontiers in Genetics
Published
2024-09-13
DOI
https://doi.org/10.3389/fgene.2024.1447971
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low prevalence of HIV in the northern Cameroon: contribution of some AIDS restriction genes and potential implications for gene therapy

Aline Tiga, Patrice Djataou, Moussa Djaouda, Elise Elong et al.
Frontiers in Genetics
HIV Research and Treatment
article

Low prevalence of HIV in the northern Cameroon: contribution of some AIDS restriction genes and potential implications for gene therapy

Aline Tiga, Patrice Djataou, Moussa Djaouda, Elise Elong, Alexis Ndjolo, Marie Nicole Ngoufack, Carine Nguefeu Nkenfou-Tchinda, Marceline Djuidje Ngounoue, Celine Nguefeu Nkenfou, Clifford Muluh, Joelle Kadji Kameni
article en

Abstract

The higher frequency of HIV-protective alleles in the northern regions may be a contributing factor to the lower prevalence of HIV. Nevertheless, this should be reinforced by other preventive and surveillance methods to guarantee the sustained low prevalence. HIV can develop resistance through the process of mutation, but the host targets themselves are genetically stable. The study of these host genetic restriction factors is of great value in the design of a practical cure for HIV infection or an effective vaccine.

Frontiers in GeneticsVol. 15
Université de Yaoundé I (CM), University of Maroua (CM), Centre International De Reference Chantal Biya (CM), Hanlim Pharm (South Korea) (KR), United Nations Children's Fund Cameroon (CM), Ministry of Higher Education (CM)
Openalex Percentile: Top 85%
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.